# RISPERIDONE
> **ANDA211220** · Abbreviated New Drug Application (Generic) · Sponsor: NANOMI · Approved 2025-09-02
## Drug
- **FDA Application Number:** ANDA211220
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RISPERIDONE
- **Generic name:** RISPERIDONE
- **Active ingredients:** RISPERIDONE
- **Dosage form:** POWDER
- **Route:** INTRAMUSCULAR
- **Marketing status:** Prescription
- **Sponsor:** NANOMI
- **Manufacturer:** Lupin Pharmaceuticals, Inc.
- **First approval:** 2025-09-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211220)
---
*MORVS · CC0 1.0*